FDA RenoProtect coverage for business development, investment, and market access teams
The FDA has approved RenoProtect, a novel therapy designed to slow the progression of diabetic kidney disease, marking a significant advancement in patient care.
We use cookies to enhance your experience, analyze traffic, and for marketing. By continuing to use our site, you consent to our use of cookies. Privacy Policy
